Join
Live feed
·
NEWSReleasevia Quantisnow
Xenetic Biosciences Inc. logo

Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform

ByQuantisnow·Wall Street's wire, on your screen.
XBIO· Xenetic Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XBIO (Xenetic Biosciences Inc.) and more on Quantisnow.